Not logged in.png)
Share.png)
SaveCRA-LICOM: a global high-frequency atmospheric and oceanic temporal gravity field product (2002-2024)
Yang, Fan; Bai, Jiahui; Liu, Hailong; Zhang, Weihang; Wu, Yi; Liu, Shuhao; Shi, Chunxiang; Zhang, Tao; Zhong, Min; Zhu, Zitong; Wang, Changqing; Forootan, Ehsan; Yu, Jiangfeng; Yu, Zipeng; Xiao, Yun Share Save Share Save Share Save Share Save Share Save SPIN1 accelerates tumorigenesis and confers radioresistance in non-small cell lung cancer by orchestrating the FOXO3a/FOXM1 axisZhong, Min; Fang, Zhi; Zou, Juntao; Chen, Xiao; Qiu, Zezhi; Zhou, Ling; Le, Yi; Chen, Zhen; Liao, Yanyu; Nie, Fengting; Wei, Xianpin; Zhan, Jinbo; Xiong, Jianping; Xiang, Xiaojun; Fang, Ziling Share Save Experimental confirmation and bioinformatics reveal biomarkers of immune system infiltration and hypertrophy ligamentum flavumLiu, Fei; Zhong, Min; Yang, Lei; Song, Chao; Chen, Chaoqi; Xu, Zhiwei; Zhang, Chi; Li, Zhifa; Wu, Xiaofei; Jiang, Chen; Chen, Feng; Yan, Qian Share Save TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathwayYang, Hui; Zhou, Hanyu; Fu, Minjie; Xu, Hao; Huang, Haoyu; Zhong, Min; Zhang, Mengying; Hua, Wei; Lv, Kun; Zhu, Guoping Share Save Share Save Share Save Share Save WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 proteinZou, Jianping; Zhou, Ling; Le, Yi; Fang, Zhi; Zhong, Min; Nie, Fengting; Wei, Xianpin; Zhang, Xiaomei; Chen, Zhen; Cai, Lingling; Wang, Heng; Xiong, Jianping; Fang, Ziling; Xiang, Xiaojun Share Save Share Save USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancerLiu, Zhen; Li, Junhe; Ding, Yun; Ma, Mei; Chen, Jun; Lei, Wan; Li, Li; Yao, Yangyang; Yu, Xin; Zhong, Min; Liao, Quan; Fang, Weidan; Fan, Linwei; Huang, Chunye; Zhong, Hongguang; Wen, Qin; Fang, Zi; Chen, Jingyi; Huang, Shanshan; Xiong, Jianpin; Xiang, Xiaojun; Deng, Jun Share Save Share Save Share Save Share Save CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axisYang, Hui; Liu, Xiaocen; Zhu, Xiaolong; Li, Xueqin; Jiang, Lan; Zhong, Min; Zhang, Mengying; Chen, Tianbing; Ma, Mingzhe; Liang, Xiuming; Lv, Kun Share Save Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsHopkins, Brian T.; Bame, Eris; Bell, Noah; Bohnert, Tonika; Bowden-Verhoek, Jon K.; Bui, Minna; Cancilla, Mark T.; Conlon, Patrick; Cullen, Patrick; Erlanson, Daniel A.; Fan, Junfa; Fuchs-Knotts, Tarra; Hansen, Stig; Heumann, Stacey; Jenkins, Tracy J.; Gua, Chuck; Liu, Ying; Liu, YuTing; Lulla, Mukush; Marcotte, Douglas; Marx, Isaac; McDowell, Bob; Mertsching, Elisabeth; Negrou, Ella; Romanowski, Michael J.; Scott, Daniel; Silvian, Laura; Yang, Wenjin; Zhong, Min Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
